RSLS News and Press, ReShape Lifesciences Inc. From 11/08/23

Third Quarter Core Operating Expenses Reduced 37% Compared to Third Quarter of 2022 Cost Reduction Plan To Reduce Operating Expenses In 2024 by Over 40% Compared to 2023 Conference Call to be Held at 5:00 pm ET Today IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Re...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

ReShape Lifesciences Inc. (RSLS) is expected to report for Q2 2024

IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the third quarter ended September 30, 2023, including...

2023-10-25 13:19:48 ET DENVER, Colo., Oct. 25, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; BioXcel Therapeutics Inc (NASDAQ: BTAI), Abri SPAC I Inc (NASDAQ: ASPA), Deutsche Bank AG (NYSE: DB), ...

2023-10-25 09:59:18 ET DENVER, Colo., Oct. 25, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BioXcel Therapeutics Inc (NASDAQ: BTAI), Abri SPAC I Inc (NASDAQ: ASPA), Deutsche Bank AG (NYSE: DB), Pagaya ...

2023-10-25 07:14:40 ET DENVER, Colo., Oct 25, 2023 ( www.247marketnews.com )- Reshape Lifesciences Inc (NASDAQ: RSLS) is trading at $0.279, up $0.19 (+212.56%), on 27.29M premarket shares traded. Its 52-week range is $0.1856 to $22.40. This hit a new 52-week low on Monday and 34-cen...

2023-10-17 12:08:30 ET More on Johnson & Johnson Johnson & Johnson: A Conservative High-Yield Dividend Aristocrat Buy Johnson & Johnson Q3 Earnings Preview: Don't Count On Different Proposition Post Kenvue Spin-Out Johnson & Johnson: The Bull Case Can...

2023-10-12 10:01:47 ET DENVER, Colo., Oct. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Jaguar Health (NASDAQ: JAGX), LL Flooring Holdings (NYSE: LL), Secoo Holding (NASDAQ: SECO), OpGen (NASDAQ: O...

2023-10-02 05:29:59 ET More on ReShape Lifesciences ReShape Lifesciences Inc. (RSLS) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on ReShape Lifesciences Historical earnings data for ReShape Lifesciences Financial information for ReSha...